Focalyx Fusion

Recall Insight

This FDA Devices action (record #Z-1243-2026) was formally reported on February 11, 2026, with the manufacturer initiating the action on December 23, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Focalyx Technologies, LLC. is listed as the recalling firm, operating out of Hialeah, FL. Federal records indicate 18 units are affected.

The documented reason for this recall is: Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biops… Distribution data in the federal record shows the product reached: Worldwide - US Nationwide distribution in the states of NY, MA, FL and the countries of ES, VE, DO.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. Because this recall is recent, remedy windows and replacement inventory are most likely still actively available from the firm or retailer. Always cross-check the recall number against the official agency page before relying on any summary.